Bio-Techne has bought University of Minnesota-founded genome editing platform operator B-Mogen Biotechnologies to solidify a business relationship that dates to 2016.

B-Mogen Biotechnologies, a US-based genome editing services spinout of University of Minnesota, has been purchased by biotech and clinical diagnostics products supplier Bio-Techne for an undisclosed sum, StarTribune reported yesterday. While terms were not disclosed, Bio-Techne confirmed it would directly fund the acquisition from its cash holdings. Founded in 2015, B-Mogen Biotechnologies provides strategic support…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.